Diploma PLC (LON:DPLM) Insider Purchases £29,460 in Stock

Diploma PLC (LON:DPLM) insider David S. Lowden purchased 750 shares of the stock in a transaction dated Friday, March 21st. The stock was purchased at an average price of GBX 3,928 ($50.85) per share, for a total transaction of £29,460 ($38,140.86).

Diploma Price Performance

Shares of LON DPLM opened at GBX 3,970 ($51.40) on Wednesday. Diploma PLC has a fifty-two week low of GBX 3,372 ($43.66) and a fifty-two week high of GBX 4,808 ($62.25). The company has a market cap of £5.30 billion, a PE ratio of 45.63, a P/E/G ratio of 2.82 and a beta of 0.75. The company has a debt-to-equity ratio of 62.17, a quick ratio of 0.80 and a current ratio of 2.17. The business has a 50-day simple moving average of GBX 4,385.96 and a two-hundred day simple moving average of GBX 4,379.51.

Diploma Increases Dividend

The business also recently announced a dividend, which was paid on Friday, January 31st. Investors of record on Thursday, January 16th were paid a GBX 42 ($0.54) dividend. The ex-dividend date of this dividend was Thursday, January 16th. This is a boost from Diploma’s previous dividend of $17.30. This represents a yield of 0.93%. Diploma’s dividend payout ratio (DPR) is 65.52%.

Analyst Upgrades and Downgrades

Separately, JPMorgan Chase & Co. increased their target price on shares of Diploma from GBX 4,370 ($56.58) to GBX 4,420 ($57.22) and gave the company a “neutral” rating in a research report on Tuesday, January 14th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of GBX 4,567.50 ($59.13).

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.